Aurinia shareholders approve amended equity plan, elect directors at 2025 AGM

Aurinia Pharmaceuticals Inc.

Shareholders approved amended Equity Incentive Plan (20,836,773 Plan Shares) at May 15, 2025 AGM.
All six director nominees elected: Kevin Tang, Jeffrey Bailey, Kathy Goetz, Peter Greenleaf, Craig Johnson, Tina Nova.
Shareholders ratified PwC as auditor (88.3M for, 5.5M against) and approved say-on-pay (58.9M for, 17.2M against).
Bylaw amendment effective May 15, 2025 gives shareholders right to set the number of directors.
Plan imposes minimum one-year vesting; up to 5% of Plan Shares may be granted with shorter vesting.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.95

Aurinia Pharmaceuticals Inc.: Effective May 15, 2025, the Company's Bylaw No. 2 was amended to provide shareholders the right to set the number of directors (effective 2025-05-15).

Change: bylaw amendment
Effective: 2025-05-15

Exact text from the filing

Pursuant to the operation of the Business Corporations Act (Alberta), effective May 15, 2025 the Company's Bylaw No. 2 (the "Bylaws") were amended to provide shareholders of the Company the right to set the number of directors.

View on SEC.gov

59 governance changes filed in the last 30 days. Browse all governance changes →

Aurinia Pharmaceuticals Inc. filing history →

Source: SEC EDGAR

accession 0001600620-25-000057

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.